Skip to main content

Trevor G. Hackman, MD, FACS

Vice Chair of Inpatient Operations and Improvement Director | Head and Neck Oncology Fellowship | Associate Professor

Specialty:

Head and neck surgical oncology, endocrine surgery, parotid surgery, transoral laser microsurgery, skull base surgery, head and neck reconstruction, minimally invasive head and neck surgery, sinus surgery.

Contact Information:

  • Appointments: (984) 974-6484
  • Surgery Scheduler: Patricia Longest (919) 966-7491
  • Administrative Coordinator: Heather Moffitt (919) 966-8927

Education:

  • MD: University of Pittsburgh, 2003
  • Internship, General Surgery, University of Pittsburgh, 2003-2004
  • Residency: Otolaryngology, University of Pittsburgh, 2004-2008
  • Fellowship: Head and Neck/Microvascular, Washington University – St. Louis, 2008-2009

Professional Experience:

  • Director, Head and Neck Oncology Fellowship, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina
  • Professor, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, 2021-present
  • Associate Professor, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, 2015-2021
  • Assistant Professor, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, 2009-2015

Recent Publications:

For a complete list of recent publications, please visit Dr. Hackman’s PubMed listing.

Open Studies:

  • 09-2146 Treatment Outcomes of Patients with Head and Neck Cancer at the University of North Carolina, Chapel Hill Approved 6/11/2017
  • 11-0289 LCCC 1037: Accuracy of Ultrasound Guided FNA in Detecting Persistent Dis-ease in Lymph Nodes of Patients with Head and Neck Squamous Cell Carcinoma after Defini-tive Chemoradiotherapy Completed 3/18/2013
  • 11-0381 RTOG 1008: A Randomized Phase II/Phase III Study of Adjuvant Concurrent Ra-diation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors Approved 10/23/2017
  • 11-1688 The Effects of Nutrition on Postoperative Morbidity in Head and Neck Cancer Pa-tients Exempt
  • 12-0646 RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer Approved 10/21/2017
  • 12-0851 LCCC 1125: Multimodality Risk Adapted Therapy including Car-boplatin/Paclitaxel/Lapatinib as Induction for Squamous Cell Carcinoma of the Head and Neck Amenable to Transoral Surgical Approaches Approved 3/13/2017
  • 12-1087 Usage of Different Flaps for the Reconstruction of Head and Neck
    Approved 9/20/2017
  • 13-3660 The Incidence of osteoradionecrosis in head and neck cancer patients treated with IMRT Exempt
  • 14-1795 LCCC 1413: De-intensification of Radiation and Chemotherapy for Favorable-Risk HPV-related Oropharyngeal SCCA Approved
  • 14-1926 Reliability and Accuracy of Ultrasonography for Detecting Vocal Cord Motion Approved 1/12/2017
  • 14-2037 Use of BRAF immunohistochemistry on cytologic samples of papillary thyroid carcinoma Exempt
  • 14-2968 Reconstruction of bony defects of the head and neck. Exempt
  • 15-1402 Treatment outcomes for patients with obstructive sleep apnea. Expired 9/7/2016
  • 15-3117 Cost Effectiveness of Virtual Surgical Planning Versus Usual Care in Mandibular and Maxillary Reconstruction Approved 2/16/2017
  • 16-0118 Cost comparison study of treatment of laryngeal cancer Approved 1/24/2017
  • 16-0997 Sialendoscopy Outcomes at UNC Approved 4/17/2017
  • 16-3263 Disparity in preoperative and intraoperative Parathyroid Hormone levels